money Business News

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

Published by on
Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy
Source: Business News

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

This story was automatically imported from our syndicated feed coverage. Full updates are being tracked closely as more details emerge from local correspondents and global news wires.

Our editorial team is continuously monitoring this topic to bring you the latest developments. Check back regularly for detailed follow-up articles, background analyses, and video broadcasts from the scene.

Reporting sponsored by News Portal Syndicated Coverage.